Digital Repository

Inhaled beclomethasone in the treatment of early COVID-19: a phase 2, double-blind, placebo-controlled, randomised trial

Show simple item record

dc.contributor.author Mettananda, C,
dc.contributor.author Peiris, C.
dc.contributor.author Abeyrathna, D.
dc.contributor.author Gunasekera, A.
dc.contributor.author Egodage, T.
dc.contributor.author Danthanarayana, C.
dc.contributor.author Pathmeswaran, A.
dc.contributor.author Ranasinha, C.
dc.date.accessioned 2024-01-09T09:23:15Z
dc.date.available 2024-01-09T09:23:15Z
dc.date.issued 2023
dc.identifier.citation Clinical Medicine.2023;23(Suppl 6):66-68 en_US
dc.identifier.issn 1470-2118 (Print)
dc.identifier.issn 1473-4893 (Electronic)
dc.identifier.uri http://repository.kln.ac.lk/handle/123456789/27178
dc.description Indexed in MEDLINE en_US
dc.description.abstract No abstract available en_US
dc.language.iso en en_US
dc.publisher The College en_US
dc.subject COVID-19 en_US
dc.title Inhaled beclomethasone in the treatment of early COVID-19: a phase 2, double-blind, placebo-controlled, randomised trial en_US
dc.type Article en_US


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Search Digital Repository


Browse

My Account